VALGANCICLOVIR 450 MG TABLET
For 30 tablets
Pharmacies pay
$57.45 filed
30 × $1.91499 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$71.07 estimated
$57.45 + $8.62 (15%) + $5.00 fee per fill = $71.07
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
VALGANCICLOVIR 450 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “valganciclovir hydrochloride” and “valganciclovir”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Ajanta Pharma USA Inc. and Camber Pharmaceuticals, Inc.
FDA lists it under 2 Established Pharmacologic Classes: Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor and Nucleoside Analog Antiviral.
The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 12 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $57.45 for 30 tablets (30 × $1.91499 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 9 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| American Health Packaging | 2 | $1.91499 per EA filed |
| Major Pharmaceuticals | 2 | $1.91499 per EA filed |
| Strides Pharma Science Limited | 2 | $1.91499 per EA filed |
| Ajanta Pharma USA Inc. | 1 | $1.91499 per EA filed |
| Aurobindo Pharma Limited | 1 | $1.91499 per EA filed |
| AvPAK | 1 | $1.91499 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $1.91499 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $1.91499 per EA filed |
| NorthStar Rx LLC | 1 | $1.91499 per EA filed |
| Not listed as a package in the FDA directory | 3 | $1.91499 per EA filed |
All 15 NDCs, with labeler and price
- 00904-6796-04 · Major Pharmaceuticals · $1.91499 per EA · eff. 2026-09-23 filed
- 00904-6796-10 · Major Pharmaceuticals · $1.91499 per EA · eff. 2026-09-23 filed
- 27241-0158-60 · Ajanta Pharma USA Inc. · $1.91499 per EA · eff. 2026-09-23 filed
- 31722-0832-60 · Camber Pharmaceuticals, Inc. · $1.91499 per EA · eff. 2026-09-23 filed
- 50268-0787-11 · not listed as a package in the FDA directory · $1.91499 per EA · eff. 2026-09-23 filed
- 50268-0787-12 · AvPAK · $1.91499 per EA · eff. 2026-09-23 filed
- 55111-0762-60 · Dr. Reddy's Laboratories Limited · $1.91499 per EA · eff. 2026-09-23 filed
- 64380-0153-01 · Strides Pharma Science Limited · $1.91499 per EA · eff. 2026-09-23 filed
- 64380-0161-01 · Strides Pharma Science Limited · $1.91499 per EA · eff. 2026-09-23 filed
- 65862-0753-60 · Aurobindo Pharma Limited · $1.91499 per EA · eff. 2026-09-23 filed
- 68084-0965-18 · not listed as a package in the FDA directory · $1.91499 per EA · eff. 2026-09-23 filed
- 68084-0965-19 · American Health Packaging · $1.91499 per EA · eff. 2026-09-23 filed
- 68084-0965-25 · American Health Packaging · $1.91499 per EA · eff. 2026-09-23 filed
- 68084-0965-95 · not listed as a package in the FDA directory · $1.91499 per EA · eff. 2026-09-23 filed
- 72603-0750-01 · NorthStar Rx LLC · $1.91499 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares an FDA nonproprietary name with VALGANCICLOVIR 450 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| VALGANCICLOVIR 450 MG TABLET this page | $1.91499 per EA filed | We don’t know yet |
| VALGANCICLOVIR HCL 50 MG/ML | $1.00585 per ML filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.